UPI: Promising pancreatic cancer treatment
Media highlights potential new cancer therapy that could be in clinical trials soon
A new multi-drug combination therapy for pancreatic cancer is inching toward clinical trials in humans, according to University of Cincinnati researchers.
The drug compound, called SapC-DOPS, combines chemotherapy with targeted therapy and is capable of killing the cells that cause a number of cancers, including pancreatic cancer, which is notoriously difficult to treat.
"Based on pre-clinical studies, it has the potential to improve pancreatic cancer treatment," Xiaoyang Qi, PhD, a professor of hematology oncology at the University of Cincinnati College of Medicine and member of the UC Cancer Center. Qi is a lead author on the study which was published in the academic journal Molecular Therapy.
The Cincinnati Enquirer also covered this research.
Featured photo of pancreatic cancer cells courtesy of National Institutes of Health. Credit/Min Yu/Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
First-ever Gen-Z Insights event hosted by UC NEXT Innovation...
April 19, 2024
In academia, the intersection of innovation, collaboration and the fresh perspectives of the University of Cincinnati NEXT Innovation Scholars (NIS) holds immense promise. As a multi-disciplinary student group of innovators, the program balances university, corporate and non-profit partners. NIS students are driven by curiosity, passion, future creation and pursuing innovation, fostering a community of forward-thinkers poised to tackle tomorrow's challenges today. Recently, these young visionaries hosted an inaugural Gen-Z Insights showcase event at the UC 1819 Innovation Hub. The packed room of attendees included 1819 corporate partners such as Kao and Main Street Ventures and distinguished faculty and staff members. All were eager to hear and learn more from NIS scholars and the industry projects they worked on throughout the year.
Media coverage and word of mouth extends DAAP art exhibit to...
April 19, 2024
Due to popular draw, the art exhibit "Rediscovering Catharina van Hemessen’s Scourging of Christ: Women Artists, Patrons, and Rulers in Renaissance Europe" has been extended at the DAAP Library through April 30.
Alabama.com: How a new self-test for HPV could be a game changer
April 19, 2024
The University of Cincinnati's Leeya Pinder was featured in an Alabama.com/Reckon article about how self-testing for HPV could make preventative care more accessible to those facing the most barriers.